Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Engineered antibody triggers powerful anti-tumor response in advanced cancers

Many advanced cancers develop resistance to treatment and become highly aggressive, often leaving patients with limited treatment options.

13 Oct 2025

Acoustofluidic technology enables rapid detection of small extracellular vesicles

Recent research has achieved significant advances in acoustofluidic technologies for efficient isolation and biomarker-specific detection of small extracellular vesicles (sEVs).

10 Oct 2025

New AI system revolutionizes drug design and vaccine development

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system capable of predicting the 3D structures and interactions of proteins, nucleic acids, small molecules, ions, and other biomolecules with remarkable precision.

10 Oct 2025

UCLA scientists uncover the role of DGRs in structuring the infant gut microbiome

Everywhere you go, you carry a population of microbes in your gastrointestinal tract that outnumber the human cells making up your body.

10 Oct 2025

New dual-target vaccine shows promise against typhoid and Salmonella

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.

8 Oct 2025

Logical Biological and Bcell Design announce strategic partnership for engineered disease state materials

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.

From Logical Biological 7 Oct 2025

FDA grants approval to begin Phase I clinical trials of heart tissue regeneration drug AD-NP1

The body's tissues can get injured in many ways, but while some injuries heal perfectly, others don't heal at all. A cut in the skin, for example, usually heals all on its own, while internal organs, such as the heart after a heart attack or the kidney after an acute injury, remain damaged, leading to diminished function.

6 Oct 2025

Moffitt awarded $22.4 million grant to lead novel studies and clinical trials for leptomeningeal disease

Researchers at Moffitt Cancer Center have been awarded a $22.4 million grant from the U.S. Department of War to lead groundbreaking studies and clinical trials for leptomeningeal disease, a devastating complication of breast and other cancers that spreads to the coverings of the brain and spinal cord.

6 Oct 2025

Newly discovered mechanism helps leukemia cells to evade the immune system

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body's immune system.

3 Oct 2025

Deadly brain cancer erodes skull bone and alters immune marrow

Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for the first time that glioblastoma-the deadliest form of brain cancer-affects not just the brain but also erodes the skull, alters the makeup of skull marrow, and interferes with the body's immune response.

3 Oct 2025

New protein map could improve diagnosis and understanding of rare ciliopathies

Attached to nearly every human cell is an antenna-like structure known as the primary cilium, which senses the cell's environment and controls how it responds to signals from its surroundings.

3 Oct 2025

Boosting the immune system to prevent cancer recurrence and improve survival

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune system prevents cancer recurrence and improves survival.

30 Sep 2025

Yale researchers develop new test for early leptospirosis detection

In a new study, Yale School of Medicine (YSM) researchers unveiled a novel diagnostic method for detecting leptospiral virulence-modifying (VM) proteins in the blood and urine of hamsters, an advance that could pave the way for early diagnosis of the tropical disease leptospirosis in humans and improved treatment options.

29 Sep 2025

Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season

In a nationwide EHR cohort of over 400,000 U.S. infants during the 2024–2025 RSV season, nirsevimab use was linked to a 77% lower risk of RSV-related hospitalization. The study also found reduced ICU admissions and intubations, supporting broad seasonal protection in routine care.

28 Sep 2025

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models.

26 Sep 2025

Researchers develop tool to predict how patients will respond to common multiple sclerosis drug

Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating multiple sclerosis.

25 Sep 2025

Scientists outline how future therapies could change type 1 diabetes care

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to stem-cell β-cell replacement and automated insulin delivery. They stress that equitable access, validated surrogate endpoints, and scalable technologies are crucial for lasting impact.

24 Sep 2025

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent, causing severe viral hemorrhagic fever with mortality rates reaching up to 40%.

24 Sep 2025

Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.

23 Sep 2025

New microfluidic-based biosensing platform helps track live antibody secretion dynamics

A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University of Texas San Antonio, has developed a new microfluidic-based biosensing platform that allows monitoring cellular secretion of monoclonal antibody in real time.

23 Sep 2025

Antibody News and Research

Further Reading

Engineered antibody triggers powerful anti-tumor response in advanced cancers

Acoustofluidic technology enables rapid detection of small extracellular vesicles

New AI system revolutionizes drug design and vaccine development

UCLA scientists uncover the role of DGRs in structuring the infant gut microbiome

New dual-target vaccine shows promise against typhoid and Salmonella

Logical Biological and Bcell Design announce strategic partnership for engineered disease state materials

FDA grants approval to begin Phase I clinical trials of heart tissue regeneration drug AD-NP1

Moffitt awarded $22.4 million grant to lead novel studies and clinical trials for leptomeningeal disease

Newly discovered mechanism helps leukemia cells to evade the immune system

Deadly brain cancer erodes skull bone and alters immune marrow

New protein map could improve diagnosis and understanding of rare ciliopathies

Boosting the immune system to prevent cancer recurrence and improve survival

Yale researchers develop new test for early leptospirosis detection

Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

Researchers develop tool to predict how patients will respond to common multiple sclerosis drug

Scientists outline how future therapies could change type 1 diabetes care

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies

New microfluidic-based biosensing platform helps track live antibody secretion dynamics

Antibodies eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery